Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. - Wikidata - awgldk - TriplyDB

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

http://www.wikidata.org/entity/Q34580491

about

FAK and paxillin, two potential targets in pancreatic cancer Systemic treatment for inoperable pancreatic adenocarcinoma: review and update Pancreatic cancer Oncolytic viral therapy for pancreatic cancer: current research and future directions Advances in chemotherapy for pancreatic cancer Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report.The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma.A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop Surgical quality data and survival after pancreatic cancer resections: a comparison of results for octogenarians and younger patients.The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Prevention of pancreatic cancer by the beta-blocker propranolol.Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study.Outcomes and prognostic factors of patients with stage IB and IIA pancreatic cancer according to the 8th edition American Joint Committee on Cancer criteria.MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study Surgical resectability of pancreatic adenocarcinoma: CTA Pancreatic cancer-improved care achievable Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging?Therapeutic options for the management of pancreatic cancer.Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Pancreatic adenocarcinoma Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center.Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedb Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Prediagnostic body mass index and pancreatic cancer survival.Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review

P2860

Q26765360-8A388F79-C65D-46B3-AAE1-7B4B147EE8DA Q26830913-31ED4BC8-4EF3-43E4-BA0D-87B36EE9823A Q27005724-B6B8D3A5-9630-4CDD-9705-90D2B485AC88 Q27011439-F1E9AB55-E239-4286-8B7C-C83ED4750F8A Q28085711-879F2256-83C8-430A-9724-8377C0D96ED8 Q30235129-FA1607F2-B955-4684-8DC9-1A9E1F831EBA Q30383858-0DACDB98-F1BD-4AD3-9611-451E2B0C85C9 Q30389448-0B3FC903-0217-4755-BF55-A492369865B5 Q30410836-442B936A-5556-4823-A8DC-39F42D27DF36 Q30452636-A18FD91F-D258-4398-B7FF-2F1AC6D6E109 Q30491447-C8DE9687-832D-4630-A03F-4EDC0E327E5D Q30538449-04CC5391-3952-4E73-9232-78A4451AFE83 Q30854744-C3C1820B-2B5C-49C9-B9A4-736E8648BD83 Q31142308-33C90888-43C7-45B2-B4F6-230BFDFCC9F2 Q33433895-38C3A8D3-86F4-4628-B2DB-835E2046BC98 Q33559203-8C8BFF1F-E7D9-4012-96C8-81CAC4782904 Q33599558-0AFCB8DB-9B9C-4020-8F81-BA6686AB7671 Q33617221-F03E41E5-89CF-4E90-9C4C-BE137A63E4DE Q33679644-31875C6C-8B17-4A91-BC36-5D1D45BBE648 Q33704284-F499C71B-BD38-434E-9320-8F24C0626E65 Q33717981-A2E85252-016A-489A-B35E-5E96E9E81EE7 Q33823212-BB3782F4-16AC-40B3-839E-8B0D73971506 Q33977366-D74CBC69-149F-441D-841A-C84650DCEC7F Q34036659-1F6B7CD8-7709-4FD9-9148-727551AA733A Q34075815-A80DAB52-F150-4B29-B64B-E95F9F2455AB Q34093776-13BAF265-AB5D-487E-8473-3F2D9AD066EA Q34093790-A60FD3B4-E210-4371-932E-A5FB26901AD6 Q34140498-83E837E9-59FC-473D-99AA-C61FBE95D621 Q34167517-54FF9A30-7803-4241-BE71-215BE2FEA48E Q34337587-FFDEFAD9-D420-4EC7-BAA8-39ED9E712525 Q34431614-FDA88063-0772-41ED-9BDE-F2BB12862246 Q34511523-6A4F4647-41A3-4BFE-9A91-EE89AC0BAD2F Q34537320-A88CE017-8161-4EFE-8C9E-490B5FE4D587 Q34635042-C5DBFB09-6542-4791-B635-FE33CD8AF866 Q34656804-31FDBA55-D7D0-4C97-B51E-189D4750CF0B Q34663583-E2B375EE-55B8-4CE3-A89D-686D57D7FA68 Q34716541-BEBBB393-E1EB-4F37-BEB9-3982D5588491 Q35177885-36700639-D4AD-4175-8C3E-451EDC4973DE Q35196518-510D5FD1-892F-4034-8E5E-390553C92930 Q35202177-9F578A33-E57C-43DA-9918-235F8066E450

P2860

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

http://www.wikidata.org/entity/Q34580491

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Validation of the 6th edition ...... the National Cancer Database.

@ast

Validation of the 6th edition ...... the National Cancer Database.

@en

Validation of the 6th edition ...... the National Cancer Database.

@nl

type

label

Validation of the 6th edition ...... the National Cancer Database.

@ast

Validation of the 6th edition ...... the National Cancer Database.

@en

Validation of the 6th edition ...... the National Cancer Database.

@nl

prefLabel

Validation of the 6th edition ...... the National Cancer Database.

@ast

Validation of the 6th edition ...... the National Cancer Database.

@en

Validation of the 6th edition ...... the National Cancer Database.

@nl

P1433

Q34580491-D8D2C186-26B8-4CB6-AD27-6037246E1E41

P1476

Q34580491-AD7520B0-D0BB-40C2-B9DE-C6BBA1A144B7

P2093

Q34580491-29799CE4-BB8C-48AC-A8B5-011D23B48E10

Q34580491-4EFADE3B-C737-4538-B15D-51B6CB4CDBB0

Q34580491-645729CE-34C4-4F12-9E33-B9AA4DC62D23

Q34580491-83B9878B-AEC7-46CC-872D-640603D29433

Q34580491-9A8C3BA8-9B73-4F89-B774-91240E2465AB

Q34580491-D9CD84B5-303F-40EF-A0F0-00AC9E12FCB5

Q34580491-E90E7CFB-F08B-4298-A5F5-0DE161890AB0

P304

Q34580491-EADA5349-C466-44B2-BC5A-4D2FF526823A

P31

Q34580491-69ED7388-6371-4D44-B420-506CCC5F8763

P356

Q34580491-24F5C14B-BC6B-4B0C-9B37-381C1DF622DD

P407

Q34580491-21C071D8-9944-4A37-94E3-46B8B88B3206

P433

Q34580491-482BD550-212C-4163-A86D-FFE2C01785E3

P478

Q34580491-AC48F3C8-9FC2-4E92-A679-CD28B7F6BE58

P577

Q34580491-C9442239-615F-4FF0-B74A-E1E83B7DF36E

P5875

Q34580491-3EBF50B6-499D-489B-8B94-604FB3E30E57

P698

Q34580491-67C2EF8E-40AE-4E63-ACF8-6AECBA40A22C

P921

Q34580491-D4E91355-B815-4D9F-851B-285068644D40

P356

P1433

P1476

Validation of the 6th edition ...... the National Cancer Database.

@en

P2093

Andrew K Stewart

http://www.w3.org/2001/XMLSchema#string

Clifford Y Ko

http://www.w3.org/2001/XMLSchema#string

David J Bentrem

http://www.w3.org/2001/XMLSchema#string

David P Winchester

http://www.w3.org/2001/XMLSchema#string

Jamie Ritchey

http://www.w3.org/2001/XMLSchema#string

Karl Y Bilimoria

http://www.w3.org/2001/XMLSchema#string

Mark S Talamonti

http://www.w3.org/2001/XMLSchema#string

P304

738-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.22852

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6257622

http://www.w3.org/2001/XMLSchema#string

P698

17580363

http://www.w3.org/2001/XMLSchema#string

P921